Scientists are currently reviewing the hepatitis B vaccine ahead of the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting next Thursday. The ACIP will vote on whether to maintain the recommendation that all babies receive their first dose of the hepatitis B vaccine on their first day of life, a strategy that has been in place since 1991. This recommendation has led to a significant decrease in infant infections in the U.S. over the years.
Epidemiologist and influenza expert Michael Osterholm and his colleagues are conducting an independent review of the birth dose of the vaccine before the upcoming ACIP meeting. Despite potential skepticism from current ACIP members towards vaccination, Osterholm believes it is essential to review the evidence and ensure that decisions are based on scientific data.
In other news, Ralph Abraham, Louisiana’s surgeon general, has been appointed as the principal deputy director at the CDC, making him the number two official at the agency under the director. Abraham is known for his skepticism towards vaccines, advocating for personal choice and doctor consultation over vaccine promotion. He has also expressed reservations about the COVID-19 vaccine and has supported making ivermectin available over the counter in Louisiana.
While Abraham’s appointment has raised concerns among some individuals, he will be stepping into a crucial leadership role at the CDC. His views on vaccines and other health-related issues will undoubtedly influence the agency’s policies and decisions in the future.
As the holiday season approaches, STAT looks back at some iconic Thanksgiving stories from the past. From discussions about stomach stretching before a feast to the impact of football on Thanksgiving traditions, these stories offer unique perspectives on the holiday season. Additionally, the latest episode of the First Opinion Podcast explores the ethics of animal research and the use of beagles in scientific studies.
In the world of healthcare news, the Trump administration has unveiled new Medicare-negotiated drug prices, while the EPA under the Trump administration plans to abandon an air pollution rule that could prevent thousands of U.S. deaths. Major health insurers like Humana and UnitedHealth are also making changes to broker commissions to avoid costly Medicare enrollees.
Overall, the healthcare landscape is constantly evolving, with new developments and challenges arising regularly. Stay informed and engaged with the latest news and updates in the field of health and medicine.
